Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entocort EC Safety in Pediatric Crohn's Disease
NCT01444092Phase 3Completed
- Sponsor
- Padagis
- Start
- Nov 2011
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of budesonide in Crohn's disease, sponsored by Padagis. Started Nov 2011; status: completed.
02
Drugs
budesonide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01444092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01444092.